Phaze Clinical Research

Executive Summary

Phaze Clinical Research is a Greece-based Contract Research Organization (CRO) founded in 2010, offering a full range of clinical trial and consulting services to pharmaceutical, biotechnology, and other CRO clients. Specializing in the Greek market, its capabilities include project management, clinical monitoring, pharmacovigilance, data management, biostatistics, and medical writing. Despite a decade of operation, the company remains a niche player with limited scale and no disclosed funding rounds or pipeline visibility, suggesting a modest competitive position relative to larger global CROs. The lack of recent news or financial data constrains the assessment of near-term growth prospects, and the company's impact is likely confined to regional clinical trials in Greece and neighboring markets. Given the absence of disclosed catalysts or significant developments, Phaze Clinical Research currently represents a low-conviction opportunity with limited near-term upside potential.

Upcoming Catalysts (preview)

• TBDExpansion into new European geographies beyond Greece30% success
• TBDStrategic partnership with a larger CRO or pharmaceutical company20% success
• TBDSigning of a major clinical trial contract with a top biopharma firm15% success